secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medpace Holdings, Inc. (MEDP)
CIK:        0001668397
Form:       8-K
Filed at:   2026-10-21T20:15:20+00:00
Accession:  0001668397-26-000034
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Medpace replaces $527M remaining buyback with new $1.0B authorization through 2028
--------------------------------------------------------------------------------

- Board terminated prior repurchase authorization effective Oct 20, 2026, with $527.0M remaining unused, and approved a new authorization of up to $1.0B of common stock through Dec 31, 2028.
- New buybacks will be funded from cash on hand via open market purchases, privately negotiated deals or Rule 10b5-1 plans; no minimum repurchase amount is required.
- Q3 results for the three and nine months ended September 30, 2026 were announced Oct 21, 2026, but Exhibit 99.1 text did not appear in the filing copy, so revenue/EPS figures are unavailable.
- CFO Kevin M. Brady signed the report; the 8-K body contains no other operating or financial detail.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1668397/000166839726000034/0001668397-26-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1668397/000166839726000034/medp-20261020.htm
  HTML page:      https://secwatch.observer/filing/0001668397-26-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer